Cargando…

Cancer-associated fibroblast heterogeneity in axillary lymph nodes drives metastases in breast cancer through complementary mechanisms

Although fibroblast heterogeneity is recognized in primary tumors, both its characterization in and its impact on metastases remain unknown. Here, combining flow cytometry, immunohistochemistry and RNA-sequencing on breast cancer samples, we identify four Cancer-Associated Fibroblast (CAF) subpopula...

Descripción completa

Detalles Bibliográficos
Autores principales: Pelon, Floriane, Bourachot, Brigitte, Kieffer, Yann, Magagna, Ilaria, Mermet-Meillon, Fanny, Bonnet, Isabelle, Costa, Ana, Givel, Anne-Marie, Attieh, Youmna, Barbazan, Jorge, Bonneau, Claire, Fuhrmann, Laetitia, Descroix, Stéphanie, Vignjevic, Danijela, Silberzan, Pascal, Parrini, Maria Carla, Vincent-Salomon, Anne, Mechta-Grigoriou, Fatima
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6972713/
https://www.ncbi.nlm.nih.gov/pubmed/31964880
http://dx.doi.org/10.1038/s41467-019-14134-w
_version_ 1783489891532800000
author Pelon, Floriane
Bourachot, Brigitte
Kieffer, Yann
Magagna, Ilaria
Mermet-Meillon, Fanny
Bonnet, Isabelle
Costa, Ana
Givel, Anne-Marie
Attieh, Youmna
Barbazan, Jorge
Bonneau, Claire
Fuhrmann, Laetitia
Descroix, Stéphanie
Vignjevic, Danijela
Silberzan, Pascal
Parrini, Maria Carla
Vincent-Salomon, Anne
Mechta-Grigoriou, Fatima
author_facet Pelon, Floriane
Bourachot, Brigitte
Kieffer, Yann
Magagna, Ilaria
Mermet-Meillon, Fanny
Bonnet, Isabelle
Costa, Ana
Givel, Anne-Marie
Attieh, Youmna
Barbazan, Jorge
Bonneau, Claire
Fuhrmann, Laetitia
Descroix, Stéphanie
Vignjevic, Danijela
Silberzan, Pascal
Parrini, Maria Carla
Vincent-Salomon, Anne
Mechta-Grigoriou, Fatima
author_sort Pelon, Floriane
collection PubMed
description Although fibroblast heterogeneity is recognized in primary tumors, both its characterization in and its impact on metastases remain unknown. Here, combining flow cytometry, immunohistochemistry and RNA-sequencing on breast cancer samples, we identify four Cancer-Associated Fibroblast (CAF) subpopulations in metastatic lymph nodes (LN). Two myofibroblastic subsets, CAF-S1 and CAF-S4, accumulate in LN and correlate with cancer cell invasion. By developing functional assays on primary cultures, we demonstrate that these subsets promote metastasis through distinct functions. While CAF-S1 stimulate cancer cell migration and initiate an epithelial-to-mesenchymal transition through CXCL12 and TGFβ pathways, highly contractile CAF-S4 induce cancer cell invasion in 3-dimensions via NOTCH signaling. Patients with high levels of CAFs, particularly CAF-S4, in LN at diagnosis are prone to develop late distant metastases. Our findings suggest that CAF subset accumulation in LN is a prognostic marker, suggesting that CAF subsets could be examined in axillary LN at diagnosis.
format Online
Article
Text
id pubmed-6972713
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-69727132020-01-22 Cancer-associated fibroblast heterogeneity in axillary lymph nodes drives metastases in breast cancer through complementary mechanisms Pelon, Floriane Bourachot, Brigitte Kieffer, Yann Magagna, Ilaria Mermet-Meillon, Fanny Bonnet, Isabelle Costa, Ana Givel, Anne-Marie Attieh, Youmna Barbazan, Jorge Bonneau, Claire Fuhrmann, Laetitia Descroix, Stéphanie Vignjevic, Danijela Silberzan, Pascal Parrini, Maria Carla Vincent-Salomon, Anne Mechta-Grigoriou, Fatima Nat Commun Article Although fibroblast heterogeneity is recognized in primary tumors, both its characterization in and its impact on metastases remain unknown. Here, combining flow cytometry, immunohistochemistry and RNA-sequencing on breast cancer samples, we identify four Cancer-Associated Fibroblast (CAF) subpopulations in metastatic lymph nodes (LN). Two myofibroblastic subsets, CAF-S1 and CAF-S4, accumulate in LN and correlate with cancer cell invasion. By developing functional assays on primary cultures, we demonstrate that these subsets promote metastasis through distinct functions. While CAF-S1 stimulate cancer cell migration and initiate an epithelial-to-mesenchymal transition through CXCL12 and TGFβ pathways, highly contractile CAF-S4 induce cancer cell invasion in 3-dimensions via NOTCH signaling. Patients with high levels of CAFs, particularly CAF-S4, in LN at diagnosis are prone to develop late distant metastases. Our findings suggest that CAF subset accumulation in LN is a prognostic marker, suggesting that CAF subsets could be examined in axillary LN at diagnosis. Nature Publishing Group UK 2020-01-21 /pmc/articles/PMC6972713/ /pubmed/31964880 http://dx.doi.org/10.1038/s41467-019-14134-w Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Article
Pelon, Floriane
Bourachot, Brigitte
Kieffer, Yann
Magagna, Ilaria
Mermet-Meillon, Fanny
Bonnet, Isabelle
Costa, Ana
Givel, Anne-Marie
Attieh, Youmna
Barbazan, Jorge
Bonneau, Claire
Fuhrmann, Laetitia
Descroix, Stéphanie
Vignjevic, Danijela
Silberzan, Pascal
Parrini, Maria Carla
Vincent-Salomon, Anne
Mechta-Grigoriou, Fatima
Cancer-associated fibroblast heterogeneity in axillary lymph nodes drives metastases in breast cancer through complementary mechanisms
title Cancer-associated fibroblast heterogeneity in axillary lymph nodes drives metastases in breast cancer through complementary mechanisms
title_full Cancer-associated fibroblast heterogeneity in axillary lymph nodes drives metastases in breast cancer through complementary mechanisms
title_fullStr Cancer-associated fibroblast heterogeneity in axillary lymph nodes drives metastases in breast cancer through complementary mechanisms
title_full_unstemmed Cancer-associated fibroblast heterogeneity in axillary lymph nodes drives metastases in breast cancer through complementary mechanisms
title_short Cancer-associated fibroblast heterogeneity in axillary lymph nodes drives metastases in breast cancer through complementary mechanisms
title_sort cancer-associated fibroblast heterogeneity in axillary lymph nodes drives metastases in breast cancer through complementary mechanisms
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6972713/
https://www.ncbi.nlm.nih.gov/pubmed/31964880
http://dx.doi.org/10.1038/s41467-019-14134-w
work_keys_str_mv AT pelonfloriane cancerassociatedfibroblastheterogeneityinaxillarylymphnodesdrivesmetastasesinbreastcancerthroughcomplementarymechanisms
AT bourachotbrigitte cancerassociatedfibroblastheterogeneityinaxillarylymphnodesdrivesmetastasesinbreastcancerthroughcomplementarymechanisms
AT kiefferyann cancerassociatedfibroblastheterogeneityinaxillarylymphnodesdrivesmetastasesinbreastcancerthroughcomplementarymechanisms
AT magagnailaria cancerassociatedfibroblastheterogeneityinaxillarylymphnodesdrivesmetastasesinbreastcancerthroughcomplementarymechanisms
AT mermetmeillonfanny cancerassociatedfibroblastheterogeneityinaxillarylymphnodesdrivesmetastasesinbreastcancerthroughcomplementarymechanisms
AT bonnetisabelle cancerassociatedfibroblastheterogeneityinaxillarylymphnodesdrivesmetastasesinbreastcancerthroughcomplementarymechanisms
AT costaana cancerassociatedfibroblastheterogeneityinaxillarylymphnodesdrivesmetastasesinbreastcancerthroughcomplementarymechanisms
AT givelannemarie cancerassociatedfibroblastheterogeneityinaxillarylymphnodesdrivesmetastasesinbreastcancerthroughcomplementarymechanisms
AT attiehyoumna cancerassociatedfibroblastheterogeneityinaxillarylymphnodesdrivesmetastasesinbreastcancerthroughcomplementarymechanisms
AT barbazanjorge cancerassociatedfibroblastheterogeneityinaxillarylymphnodesdrivesmetastasesinbreastcancerthroughcomplementarymechanisms
AT bonneauclaire cancerassociatedfibroblastheterogeneityinaxillarylymphnodesdrivesmetastasesinbreastcancerthroughcomplementarymechanisms
AT fuhrmannlaetitia cancerassociatedfibroblastheterogeneityinaxillarylymphnodesdrivesmetastasesinbreastcancerthroughcomplementarymechanisms
AT descroixstephanie cancerassociatedfibroblastheterogeneityinaxillarylymphnodesdrivesmetastasesinbreastcancerthroughcomplementarymechanisms
AT vignjevicdanijela cancerassociatedfibroblastheterogeneityinaxillarylymphnodesdrivesmetastasesinbreastcancerthroughcomplementarymechanisms
AT silberzanpascal cancerassociatedfibroblastheterogeneityinaxillarylymphnodesdrivesmetastasesinbreastcancerthroughcomplementarymechanisms
AT parrinimariacarla cancerassociatedfibroblastheterogeneityinaxillarylymphnodesdrivesmetastasesinbreastcancerthroughcomplementarymechanisms
AT vincentsalomonanne cancerassociatedfibroblastheterogeneityinaxillarylymphnodesdrivesmetastasesinbreastcancerthroughcomplementarymechanisms
AT mechtagrigorioufatima cancerassociatedfibroblastheterogeneityinaxillarylymphnodesdrivesmetastasesinbreastcancerthroughcomplementarymechanisms